Merck’s Perlmutter Is Retiring, Handing Over Keytruda To Li
New R&D Head Comes From Discovery And Translation Group
Merck Research Laboratories president Roger Perlmutter returned to the company when its R&D was at a crossroads. Now he is retiring and handing the company’s post-Keytruda growth over to SVP Dean Li.
